跳至主要内容
临床试验/ITMCTR1900002640
ITMCTR1900002640尚未招募未知

A multicenter prospective clinical study for the treatment of spleen and kidney insufficiency metrorrhagia and metrostaxis with Lingnan Hemostatic Prescription Erren Decoction

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
13 至 55(—)
性别
Female

入选标准

  • 1. Between the ages of 13 and 55 years.
  • 2. (1) suddenly a lot of violence under the vaginal bleeding; (2) blood dripping more than 14 days (in line with one of them).
  • 3. (1) dark red or light red; (2) by thin (accord with one of them).
  • 4. (1) weak waist and knees, chills and cold limbs, insomnia, tinnitus, and loss of libido; (2) loose stool, fatigue, poor diet, abnormal complexion (yellow or white) (at least in line with 1, 2 in each).
  • 5. Tongue veins: the tongue is light and dark, with thin white coating and heavy and fine veins.
  • 6. The subject voluntarily participates in the study and has signed the informed consent.

排除标准

  • 1. Vaginal bleeding caused by pregnancy.
  • 2. Organic lesions, such as genital malignant tumor, uterine fibroids, adenomyosis and other abnormal uterine bleeding.
  • 3. Abnormal uterine bleeding caused by reproductive tract infection.
  • 4. Bleeding of vulva, vagina and cervix.
  • 5. Abnormal uterine bleeding caused by cardiovascular diseases, liver diseases, blood system diseases, etc.
  • 6. Hemoglobin less than 90g/L.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验